Last updated on February 2019

Evaluate TV-46000 as Maintenance Treatment in Adult Patients With Schizophrenia


Brief description of study

The purpose of the study is to evaluate the efficacy, safety, and tolerability of different dose regimens of TV-46000 administered subcutaneously as compared to placebo during maintenance treatment in adult patients with schizophrenia. The study will include male and female patients, 18 to 65 years of age, who have a confirmed diagnosis of schizophrenia, are clinically stable, and are eligible for risperidone treatment.

Clinical Study Identifier: NCT03503318

Contact Investigators or Research Sites near you

Start Over

Teva U.S. Medical Information

Teva Investigational Site 14815
Pico Rivera, CA United States
0.62miles
  Connect »

Teva U.S. Medical Information

Teva Investigational Site 14803
Norwalk, CA United States
5.42miles
  Connect »

Teva U.S. Medical Information

Teva Investigational Site 14794
Bellflower, CA United States
6.87miles
  Connect »

Teva U.S. Medical Information

Teva Investigational Site 14817
La Habra, CA United States
9.13miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.